Although other studies have shown that siRNA can be used in human vessels without causing damage (Kadlec et al., 2017), it is also plausible that the transfection reagent induces endothelial dysfunction and the effect of osmotin at this concentration produces a more modest effect than adiponectin. Here, ADIPOQ is linked to endothelial dysfunction.